Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study.
Lize VanakenF J S H Sherida Woei-A-JinRita Van GinderdeurenChristophe M DerooseAnnouschka LaenenGuy MissottenDietmar Rudolf ThalOliver BechterPatrick SchöffskiPaul ClementPublished in: Acta oncologica (Stockholm, Sweden) (2023)
Although we documented responses to ICI, our analyses do not demonstrate an OS benefit of ICI over alternative treatment strategies for MUM. However, local treatment options, whether liver-directed or for oligometastatic disease, may be beneficial and should be considered.